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The purpose of this study was to investigate the effects of various antiglaucoma drugs, including timolol,
betaxolol, carteolol, levobunolol, dipivefrin, and pilocarpine, on cellular proliferation in cultured human
corneal keratocytes. Human corneal keratocytes were cultured with RPMI-1640 medium containing 10%
fetal bovine serum. Antiglaucoma drugs were prepared from original concentrations to dilutions of 1/10,
1/100, and 1/1,000. After exposure to drugs for 100 minutes, cellular proliferation was estimated by [3H]
thymidine uptake methodology. It was found that cellular proliferation in corneal keratocytes was inhibited
by only a 1/10 dilution of various drugs including timolol, betaxolol, carteolol, levobunolol, dipivefrin, and
pilocarpine. The [3H]thymidine uptake values were significantly inhibited to 63%, 18%, 87%, 68%, 55%, and
67% by a 1/10 dilution of the above drugs. However, the cellular proliferation was also significantly
suppressed by 0.01 mg/mL of benzalkonium chloride preservative. It is shown that the inhibition of cellular
proliferation by high concentrations of antiglaucoma drugs may result from the benzalkonium chloride
preservative contained in these drugs.
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It is now recognized that glaucoma is a chronic disease
caused by the death and subsequent loss of ganglion cells
and their axons in the optic nerve [1]. Patients with glaucoma
must administer antiglaucoma drugs for a long period of
time before their elevated intraocular pressure is well
controlled by alternatives such as laser therapy or surgery.
Under these circumstances, the cornea is continuously
soaked in antiglaucoma drugs over a long period of time;
thus, the physiologic function of the cornea may be changed
gradually in the process of drug administration. Some
evidence indicates that timolol suppresses cellular
proliferation of corneal epithelial cells [2,3]. Other reports
also show that loss of corneal endothelial cells occurs with
long-term topical epinephrine therapy in glaucoma patients
[4]. After 1 year of treatment, the mean age percent loss in
endothelial cell density of the human cornea from baseline
was 4.5% and 4.2% for timolol- and betaxolol-treated groups,
respectively [5]. Thus, antiglaucoma drugs may influence
corneal cells. However, the effects of antiglaucoma drugs
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on corneal keratocytes have been poorly investigated, even
though ever more antiglaucoma drugs are becoming
available on the market. In the present study, we investigated
the effects of various commercially available antiglaucoma
drugs, including timolol, betaxolol, carteolol, levobunolol,
dipivefrin, and pilocarpine, on cellular proliferation in
cultured human corneal keratocytes.
MATERIALS AND METHODS
Materials
Culture materials, including trypsin, minimal essential
medium, glutamine, gentamicin, and fetal bovine serum,
were obtained from GIBCO (Grand Island, NY). [3H]
thymidine (specific activity 15.0 Ci/mmol) was purchased
from New England Nuclear (Du Pont, Boston, MA).
Commercially available preparations of antiglaucoma drugs
were prepared with serum-free medium to make three
dilutions of these drugs of 1/10, 1/100, and 1/1,000 for all
experiments. The drugs obtained were: 0.25% (5.8 mM)
timolol (Timoptol; Merck, Sharp & Dohme-Chibret,
containing 0.048 mg/mL benzalkonium chloride), 0.5%
(16.2 mM) betaxolol (Betoptic; Alcon, containing 0.1 mg/
mL benzalkonium chloride), 1% (68 mM) carteolol
(Arteoptic; Otsuka, containing 0.005 mg/mL benzalkonium
chloride), 0.5% (17.1 mM) levobunolol (Bunolgan; Allergan,
containing 0.04 mg/mL benzalkonium chloride), 0.1% (2.8
mM) dipivefrin (Propine; Allergan, containing 0.04 mg/mL
benzalkonium chloride), and 1% (40.8 mM) pilocarpine
(Spersacarpine; Dispersa, containing 0.1 mg/mL
benzalkonium chloride). All other chemicals were obtained
from Merck (Darmstadt, Germany).
Culture of human corneal keratocytes
Human corneal keratocyte primary cultures were obtained
and cultured using human donor corneas that had been
discarded after transplantation, as described in an earlier
publication [6,7]. The endothelial and epithelial layers
were removed, then the corneal stroma was minced into
cubes of about 1 mm and plated in a culture flask for
culture of keratocytes. The culture medium for cells
consisted of RPMI-1640 medium containing 10% fetal
bovine serum, 3.8 mM L-glutamine, and 50 μg/mL
gentamicin. Culture conditions were maintained with a
humidified chamber containing 5% CO2 at 37°C, and the
medium was changed every 2 or 3 days. The cells usually
appeared within 3–7 days. The cells used in this experiment
were from passage 3 to passage 5.
Statistics
The values are presented as mean ±  SEM from three
experiments with triplicate determinations. All data were
analyzed with analysis of variance followed by comparison
with the Dunnett test. The values were considered significantly
different from corresponding controls at p < 0.05.
RESULTS
To estimate the effects of antiglaucoma drugs on cellular
proliferation, [3H]thymidine uptake was performed after
treating the cells with various antiglaucoma drugs at
1/10, 1/100, and 1/1,000 dilutions for 100 minutes. We
found that the [3H]thymidine uptake in cultured human
corneal keratocytes was significantly inhibited by 580 μM
timolol to 63% ±  3% when compared with the control
group (which was assumed as 100% response) (Figure 1).
However, 58 and 5.8 μM timolol had no effect on cellular
proliferation. After treatment with a selective ` 1-adrenergic
antagonist, betaxolol, at the concentrations of 1,620, 162,
and 16.2 μM, the cellular [3H]thymidine uptake was to 18%
±  5%, 95% ± 4%, and 101% ±  3%, respectively (Figure 2).
Only the 1,620 μM concentration of betaxolol showed an
inhibitory effect on cellular proliferation. In the presence
of nonselective `-adrenergic antagonists including
levobunolol and carteolol, the cellular [3H]thymidine
uptake was significantly inhibited by both drugs only at
the 1/10 diluted concentration. When cells were treated
with 6,800 μM carteolol for 100 minutes, the value of
[3H]thymidine uptake was significantly inhibited to
87% ± 4% in comparison with the control group (Figure 3).
Again, only 1,710 μM and not 171 and 17.1 μM levobunolol
significantly inhibited cellular proliferation to 68% ±  4%
when compared with the control value (Figure 4). After
addition of the sympathomimetic drug dipivefrin with
280, 28, and 2.8 μM for 100 minutes, the [3H]thymidine
uptake value was significantly inhibited only by 280 μM
and not by 28 and 2.8 μM concentrations to 55% ±  3% in
comparison with the control group (Figure 5). In the case
of the parasympathomimetic drug pilocarpine, only the
1/10 dilution (4,080 μM) and not the 408 and 40.8 μM
drug concentrations significantly inhibited [3H]thymidine
uptake to 67% ± 3% in comparison with the control value
(Figure 6).
All of the commercial antiglaucoma drugs described
above contain benzalkonium chloride as a preservative.
To estimate the effect of benzalkonium chloride on
corneal keratocytes, we tested various concentrations of
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Figure 1. Dose-dependent effects of timolol on cellular [3H]thymidine
uptake in cultured human corneal keratocytes. Cells were exposed to
timolol at the concentrations of 580, 58, or 5.8 μM for 100 minutes. All
data are presented as percentage of control cells. Data are presented as
mean ± SEM (n = 3; triplicates averaged from three different experiments).
*p < 0.05 compared with control.
Figure 2. Dose-dependent effects of betaxolol on cellular [3H]thymidine
uptake in cultured human corneal keratocytes. Cells were exposed to
betaxolol at concentrations of 1,620, 162, or 16.2 μM for 100 minutes.
All data are presented as percentage of control cells. Data are presented
as mean ±  SEM (n = 3; triplicates averaged from three different
experiments). *p < 0.05 compared with control.
Figure 3. Dose-dependent effects of carteolol on cellular [3H]thymidine
uptake in cultured human corneal keratocytes. Cells were exposed to
carteolol at concentrations of 6,800, 680, or 68 μM for 100 minutes. All
data are presented as percentage of control cells. Data are presented as
mean ± SEM (n = 3; triplicates averaged from three different experiments).
*p < 0.05 compared with control.
benzalkonium chloride alone, at 0.01, 0.001, and 0.0001 mg/
mL in [3H]thymidine uptake experiments. The results
demonstrated that only at 0.01 mg/mL concentrations did
benzalkonium chloride significantly inhibit [3H]thymidine
uptake to 51% ± 3% in comparison with the control group
(data not shown).
Figure 4. Dose-dependent effects of levobunolol on cellular [3H]thymidine
uptake in cultured human corneal keratocytes. Cells were exposed
to levobunolol at concentrations of 1,710, 171, and 17.1 μM for 100
minutes. All data are presented as percentage of control cells. Data are
presented as mean ± SEM (n = 3; triplicates averaged from three different
experiments). *p < 0.05 compared with control.
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DISCUSSION
Our experimental data show that the antiglaucoma agents
betaxolol, timolol, levobunolol, carteolol, dipivefrin, and
pilocarpine at high concentrations have potent effects on
inhibiting cellular proliferation in cultured human corneal
keratocytes.
Corneal keratocytes are a type of fibroblast and are found
throughout the stroma between the stroma lamellae. They
play a crucial role in producing ground substance and collagen
fibrils during embryogenesis and after corneal injury [8].
Although several studies have demonstrated that timolol
suppresses cellular proliferation in corneal epithelial cells
[2,3] and that loss of corneal endothelial cells occurs with
long-term topical epinephrine therapy in glaucoma patients
[4], as yet, little is known about whether antiglaucoma drugs
influence the physiologic functions of corneal keratocytes,
even though increasing numbers of glaucoma patients have
used the antiglaucoma drugs for a very long time. When the
corneal stroma is damaged or during the wound healing
process, such as following corneal injury or the refractive
surgeries, photorefractive keratectomy (PRK) and laser-
assisted in situ keratomileusis (LASIK), the corneal keratocytes
transform from quiescent keratocytes to mitotic fibroblasts
[9]. Under these circumstances, cellular proliferation ability
plays a crucial role in the regulation of corneal physiologic
function. In the present study, we found that high
Figure 5. Dose-dependent effects of dipivefrin on cellular [3H]thymidine
uptake in cultured human corneal keratocytes. Cells were exposed to
dipivefrin at concentrations of 280, 28 or 2.8 μM for 100 minutes. All
data are presented as percentage of control cells. Data are presented as
mean ± SEM (n = 3; triplicates averaged from three different experiments).
*p < 0.05 compared with control.
Figure 6. Dose-dependent effects of pilocarpine on cellular [3H]thymidine
uptake in cultured human corneal keratocytes. Cells were exposed
to pilocarpine at concentrations of 4,080, 408, and 40.8 μM for 100
minutes. All data are presented as percentage of control cells. Data are
presented as mean ± SEM (n = 3; triplicates averaged from three different
experiments). *p < 0.05 compared with control.
concentrations of various antiglaucoma drugs inhibited
cellular proliferation in corneal keratocytes. Thus, careful
monitoring of the process of wound healing in stroma after
corneal injury or refractive surgery is needed, especially in
patients on long-term treatment with antiglaucoma drugs.
According to our previously published data, pilocarpine
stimulates cellular proliferation in cultured human Tenon’s
fibroblast cells as a result of its methylcellulose content [10].
However, in the present study, we found that pilocarpine
inhibited cellular proliferation with three diluted
concentrations in cultured human corneal keratocytes,
although both cell types are fibroblasts [8,10].
Benzalkonium chloride is one of the most commonly
used preservatives in ophthalmic preparations, especially
in antiglaucoma drugs.  High concentrations of
benzalkonium chloride may result in corneal damage [11].
In the present study, we found that all 1/10 diluted
concentrations of antiglaucoma drugs suppressed cellular
proliferation. Moreover, benzalkonium chloride alone at
0.01 mg/mL significantly inhibited [3H]thymidine uptake
in corneal keratocytes. This toxic effect of benzalkonium
chloride at high concentration may interfere with normal
physiologic function, especially with respect to cellular
proliferation of corneal stromal cells. Evidence also exists
that the use of benzalkonium chloride-preserved viscoelastic
material in cataract surgery leads to penetrating keratoplasty
and striate keratopathy [12].
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In summary, cellular proliferation of corneal keratocytes
were significantly inhibited by many commercial
antiglaucoma drugs, especially at high concentrations.
Thus, patients on long-term therapy with antiglaucoma
drugs must be carefully monitored with respect to changes
in the corneal stroma.
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